Skip to content
10-Q

Quarterly Report

ClearPoint Neuro, Inc. CLPT

0001193125-26-221890

← back to feed
Filed
May 13, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 7, 2026 29.99M sh
Shares Diluted Q1 2026 · Mar 31, 2026 29.55M sh
Shares Diluted Q1 2026 · Mar 31, 2025 27.72M sh
Capex Q1 2026 · Mar 31, 2026 $645K
Capex Q1 2026 · Mar 31, 2025 $183K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$7.97M
Operating Cash Flow Q1 2026 · Dec 31, 2025 −$23.9M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$6.17M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $35.59M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $45.92M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $12.39M
Stockholders Equity Q1 2026 · Mar 31, 2026 $18.84M
Stockholders Equity Q1 2026 · Dec 31, 2025 $28.02M
Stockholders Equity Q1 2026 · Mar 31, 2025 $19.99M
Stockholders Equity Q1 2026 · Dec 31, 2024 $25.39M
Current Liabilities Q1 2026 · Mar 31, 2026 $9.48M
Current Liabilities Q1 2026 · Dec 31, 2025 $10.77M
Total Liabilities Q1 2026 · Mar 31, 2026 $74.58M
Total Liabilities Q1 2026 · Dec 31, 2025 $69.73M
Current Assets Q1 2026 · Mar 31, 2026 $54.88M
Current Assets Q1 2026 · Dec 31, 2025 $63.6M
Total Assets Q1 2026 · Mar 31, 2026 $93.42M
Total Assets Q1 2026 · Dec 31, 2025 $97.75M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.32
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.22
Eps Basic Q1 2026 · Mar 31, 2026 −$0.32
Eps Basic Q1 2026 · Mar 31, 2025 −$0.22
Sga Expense Q1 2026 · Mar 31, 2026 $5M
Sga Expense Q1 2026 · Mar 31, 2025 $4.08M
Rd Expense Q1 2026 · Mar 31, 2026 $4.52M
Rd Expense Q1 2026 · Mar 31, 2025 $3.38M
Net Income Q1 2026 · Mar 31, 2026 −$9.55M
Net Income Q1 2026 · Mar 31, 2025 −$6.03M
Operating Income Q1 2026 · Mar 31, 2026 −$8.48M
Operating Income Q1 2026 · Mar 31, 2025 −$6.16M
Gross Profit Q1 2026 · Mar 31, 2026 $7.76M
Gross Profit Q1 2026 · Mar 31, 2025 $5.13M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $4.37M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $3.35M
Revenue Q1 2026 · Mar 31, 2026 $12.13M
Revenue Q1 2026 · Mar 31, 2025 $8.49M